Curriculum Vitaes

Minoru Omi

  (尾身 実)

Profile Information

Affiliation
School of Medicine Faculty of Medicine, Fujita Health University
Degree
博士(理学)(東北大学)

researchmap Member ID
6000015890

Research Interests

 3

Research History

 6

Major Papers

 18
  • John B. Lees‐Shepard, Kaitlyn Flint, Melanie Fisher, Minoru Omi, Kelsey Richard, Michelle Antony, Po Jung Chen, Sumit Yadav, David Threadgill, Nita J. Maihle, Caroline N. Dealy
    Developmental Dynamics, 251(1) 193-212, Nov 27, 2021  Peer-reviewed
  • Tokuichi Iguchi, Yuichiro Oka, Misato Yasumura, Minoru Omi, Kazuki Kuroda, Hideshi Yagi, Min-Jue Xie, Manabu Taniguchi, Martin Bastmeyer, Makoto Sato
    The Journal of Neuroscience, 41(22) 4795-4808, Apr 27, 2021  Peer-reviewed
    Coordination of skilled movements and motor planning relies on the formation of regionally restricted brain circuits that connect cortex with subcortical areas during embryonic development. Layer 5 neurons that are distributed across most cortical areas innervate the pontine nuclei (basilar pons) by protrusion and extension of collateral branches interstitially along their corticospinal extending axons. Pons-derived chemotropic cues are known to attract extending axons, but molecules that regulate collateral extension to create regionally segregated targeting patterns have not been identified. Here, we discovered thatEphA7andEfnA5are expressed in the cortex and the basilar pons in a region-specific and mutually exclusive manner, and that their repulsive activities are essential for segregating collateral extensions from corticospinal axonal tracts in mice. Specifically,EphA7andEfnA5forward and reverse inhibitory signals direct collateral extension such thatEphA7-positive frontal and occipital cortical areas extend their axon collaterals into theEfnA5-negative rostral part of the basilar pons, whereasEfnA5-positive parietal cortical areas extend their collaterals into theEphA7-negative caudal part of the basilar pons. Together, our results provide a molecular basis that explains how the corticopontine projection connects multimodal cortical outputs to their subcortical targets. SIGNIFICANCE STATEMENTOur findings put forward a model in which region-to-region connections between cortex and subcortical areas are shaped by mutually exclusive molecules to ensure the fidelity of regionally restricted circuitry. This model is distinct from earlier work showing that neuronal circuits within individual cortical modalities form in a topographical manner controlled by a gradient of axon guidance molecules. The principle that a shared molecular program of mutually repulsive signaling instructs regional organization—both within each brain region and between connected brain regions—may well be applicable to other contexts in which information is sorted by converging and diverging neuronal circuits.
  • Naoki Yahata, Yuji Matsumoto, Minoru Omi, Naoki Yamamoto, Ryuji Hata
    Scientific Reports, 7(1), Nov 14, 2017  Peer-reviewed
    Abstract Induced pluripotent stem cells (iPSCs) are suitable for studying mitochondrial diseases caused by mitochondrial DNA (mtDNA) mutations. Here, we generated iPSCs from a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) with the m.13513G>A mutation. The patient’s dermal fibroblasts were reprogrammed, and we established two iPSC clones with and without mutant mtDNA. Furthermore, we tried to decrease mutant mtDNA level in iPSCs using transcription activator-like effector nucleases (TALENs). We originally engineered platinum TALENs, which were transported into mitochondria, recognized the mtDNA sequence including the m.13513 position, and preferentially cleaved G13513A mutant mtDNA (G13513A-mpTALEN). The m.13513G>A heteroplasmy level in MELAS-iPSCs was decreased in the short term by transduction of G13513A-mpTALEN. Our data demonstrate that this mtDNA-targeted nuclease would be a powerful tool for changing the heteroplasmy level in heteroplasmic iPSCs, which could contribute to elucidation of the pathological mechanisms of mitochondrial diseases caused by mtDNA mutations.
  • Minoru Omi, Harukazu Nakamura
    DEVELOPMENT GROWTH & DIFFERENTIATION, 57(2) 135-145, Feb, 2015  Peer-reviewedLead authorCorresponding author
  • Minoru Omi, Hidekiyo Harada, Yuji Watanabe, Jun-ichi Funahashi, Harukazu Nakamura
    DEVELOPMENT, 141(10) 2131-2138, May, 2014  Peer-reviewedLead author
  • Minoru Omi, Hidekiyo Harada, Harukazu Nakamura
    JOURNAL OF COMPARATIVE NEUROLOGY, 519(13) 2615-2621, Sep, 2011  Peer-reviewedLead author
  • Minoru Omi, Melanie Fisher, Nita J. Maihle, Caroline N. Dealy
    Developmental Dynamics, 233(2) 288-300, Jun, 2005  Peer-reviewedLead author
  • Chi-Kuang Leo Wang, Minoru Omi, Deborah Ferrari, Hsu-Chen Cheng, Gail Lizarraga, Hsian-Jean Chin, William B Upholt, Caroline N Dealy, Robert A Kosher
    Developmental Biology, 269(1) 109-122, May, 2004  Peer-reviewed
  • Minoru Omi, Rosalie Anderson, Ken Muneoka
    Developmental Biology, 250(2) 292-304, Oct, 2002  Peer-reviewedLead author
  • Minoru Omi, Mika Sato-Maeda, Hiroyuki Ide
    International Journal of Developmental Biology, 44(4) 381-388, Jun, 2000  Peer-reviewedLead author
  • Minoru Omi, Hiroyuki Ide
    Development, Growth and Differentiation, 38(4) 419-428, Aug, 1996  Lead author

Misc.

 14

Books and Other Publications

 4

Presentations

 28

Teaching Experience

 6

Research Projects

 12